Search research articles
Contact Us
Filters
Showing results (151-160 of 178) with videos related to
Page
of 18
Sort By:
The Oncologist
|
October 10, 2019
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer
Margaret E Gatti-Mays, Jason M Redman, Renee N Donahue, et al.
The Oncologist
|
March 11, 2022
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer
Jason M Redman, Yo-Ting Tsai, Benjamin A Weinberg, et al.
JAMA Oncology
|
February 20, 2025
Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical Trial
Charalampos S Floudas, Meghali Goswami, Renee N Donahue, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2020
Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
Houssein Abdul Sater, Jennifer L Marté, Renee N Donahue, et al.
Cancer Immunology, Immunotherapy : CII
|
March 21, 2025
PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer
Charalampos S Floudas, Meghali Goswami, Renee N Donahue, et al.
Journal for Immunotherapy of Cancer
|
December 16, 2020
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies
Julius Strauss, Margaret E Gatti-Mays, Byoung Chul Cho, et al.
Nature
|
March 3, 2016
A repeating fast radio burst
L G Spitler, P Scholz, J W T Hessels, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2018
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
Fatima Karzai, David VanderWeele, Ravi A Madan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2020
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response
Fatima Karzai, Stephanie M Walker, Scott Wilkinson, et al.
Nature
|
January 6, 2017
A direct localization of a fast radio burst and its host
S Chatterjee, C J Law, R S Wharton, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 178) with videos related to
Sort By:
Page
of 18
The Oncologist
|
October 10, 2019
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer
Margaret E Gatti-Mays, Jason M Redman, Renee N Donahue, et al.
The Oncologist
|
March 11, 2022
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer
Jason M Redman, Yo-Ting Tsai, Benjamin A Weinberg, et al.
JAMA Oncology
|
February 20, 2025
Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical Trial
Charalampos S Floudas, Meghali Goswami, Renee N Donahue, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2020
Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
Houssein Abdul Sater, Jennifer L Marté, Renee N Donahue, et al.
Cancer Immunology, Immunotherapy : CII
|
March 21, 2025
PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer
Charalampos S Floudas, Meghali Goswami, Renee N Donahue, et al.
Journal for Immunotherapy of Cancer
|
December 16, 2020
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies
Julius Strauss, Margaret E Gatti-Mays, Byoung Chul Cho, et al.
Nature
|
March 3, 2016
A repeating fast radio burst
L G Spitler, P Scholz, J W T Hessels, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2018
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
Fatima Karzai, David VanderWeele, Ravi A Madan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2020
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response
Fatima Karzai, Stephanie M Walker, Scott Wilkinson, et al.
Nature
|
January 6, 2017
A direct localization of a fast radio burst and its host
S Chatterjee, C J Law, R S Wharton, et al.
Page
of 18